A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
398
Drug: Ribostat riboflavin and sodium iodide ophthalmic solution Device: UV-3000 ultraviolet A light source
Drug: placebo ophthalmic solution Device: UV-3000 light source
Schwartz Laser Eye Center
Scottsdale, Arizona, United States
Catalina Eye Center
Tucson, Arizona, United States
Inland Eye Specialists
Murrieta, California, United States
Best Spectacle-Corrected Distance Visual Acuity (BSCDVA)
BSCDVA will be assessed using Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity testing charts. The score ranges from 0 to 100, with a higher score representing better visual functioning.
Time frame: Baseline to 12 months
Vision-related Quality of Life as Assessed by the National Eye Institute 25-Item Visual Function Questionnaire (NEI-VFQ-25)
The score on the NEI-VFQ-25 ranges from 0 to 100, with a higher score indicating greater functioning.
Time frame: Baseline to 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Colorado
Aurora, Colorado, United States
Chicago Cornea Consultants
Highland Park, Illinois, United States
Claris Vision LLC Eye Health Vision Centers - Dartmouth
North Dartmouth, Massachusetts, United States
Truhlsen Eye Institute
Omaha, Nebraska, United States
Providence Eye and Laser Specialists
Charlotte, North Carolina, United States
VRF Eye Specialty Group
Memphis, Tennessee, United States
Dell Laser Consultants
Austin, Texas, United States
...and 2 more locations